RANKL blockade inhibits cancer growth through reversing the tolerogenic profile of tumor-infiltrating (plasmacytoid) dendritic cells

Charlotte Pilard, Patrick Roncarati, Marie Ancion, Margaux Luyckx, Michael Renard, Celia Reynders, Thomas Lerho, Florian Poulain, Diane Bruyere, Alizee Lebeau, Elodie Hendrick, Rebekah Crake, Raphael Peiffer, Marie-Julie Nokin, Olivier Peulen, Philippe Delvenne, Pascale Hubert, Michael Herfs

Open source

DOI
10.1136/jitc-2024-010753
Published
2025-03
Container
Journal for ImmunoTherapy of Cancer
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2024-010753,
  title = {RANKL blockade inhibits cancer growth through reversing the tolerogenic profile of tumor-infiltrating (plasmacytoid) dendritic cells},
  author = {Charlotte Pilard and Patrick Roncarati and Marie Ancion and Margaux Luyckx and Michael Renard and Celia Reynders and Thomas Lerho and Florian Poulain and Diane Bruyere and Alizee Lebeau and Elodie Hendrick and Rebekah Crake and Raphael Peiffer and Marie-Julie Nokin and Olivier Peulen and Philippe Delvenne and Pascale Hubert and Michael Herfs},
  year = {2025},
  journal = {Journal for ImmunoTherapy of Cancer},
  doi = {10.1136/jitc-2024-010753},
  url = {https://doi.org/10.1136/jitc-2024-010753}
}

RIS

TY  - JOUR
TI  - RANKL blockade inhibits cancer growth through reversing the tolerogenic profile of tumor-infiltrating (plasmacytoid) dendritic cells
AU  - Charlotte Pilard
AU  - Patrick Roncarati
AU  - Marie Ancion
AU  - Margaux Luyckx
AU  - Michael Renard
AU  - Celia Reynders
AU  - Thomas Lerho
AU  - Florian Poulain
AU  - Diane Bruyere
AU  - Alizee Lebeau
AU  - Elodie Hendrick
AU  - Rebekah Crake
AU  - Raphael Peiffer
AU  - Marie-Julie Nokin
AU  - Olivier Peulen
AU  - Philippe Delvenne
AU  - Pascale Hubert
AU  - Michael Herfs
PY  - 2025
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2024-010753
UR  - https://doi.org/10.1136/jitc-2024-010753
ER  - 

APA

Pilard, C., Roncarati, P., Ancion, M., Luyckx, M., Renard, M., Reynders, C., Lerho, T., Poulain, F., Bruyere, D., Lebeau, A., Hendrick, E., Crake, R., Peiffer, R., Nokin, M., Peulen, O., Delvenne, P., Hubert, P., & Herfs, M. (2025). RANKL blockade inhibits cancer growth through reversing the tolerogenic profile of tumor-infiltrating (plasmacytoid) dendritic cells. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2024-010753

Source records